BHST: BioHarvest Company Value to Net Income

Corporate emblem and logo of BioHarvest Sciences, Inc. (BHST)

BioHarvest Sciences (BHST) is implementing the innovative Bio-Plant CELL method for the industrial production of pure plant components without the use of pesticides. The company outsources logistics and packaging to contractors while maintaining the secrecy of key patents internally. This trading chart featuring the -3.30 metric complements the analysis of a business that is scaling its CELLICITATION system to supply raw materials to the nutraceutical sector and expand its influence in the pharmaceutical market.

BHST BioHarvest Sciences Inc: Price to Earnings Ratio in the range 11/13/2024 - 11/13/2026

Comprehensive metric breakdowns and analytics for BioHarvest (BHST)

- price and consensus price forecast:
Stock Price bioharvest.com|BHST - Consensus Target
- market capitalization information:
Market Value BioHarvest Sciences Inc.|BHST - Total Company Value
- balance sheet net asset value indicators:
Net Asset Value per Share BioHarvest Sciences|BHST - Company Net Assets|Market Cap to Book Value Multiple bioharvest.com|BHST - Company Total Assets
- company liabilities and liquidity data:
All Debt to Shareholders' Equity Ratio BioHarvest Sciences|BHST - Long-Term Debt to Capital|Current Liabilities to Capital BioHarvest Sciences Inc|BHST - Company Debts|Debt to Net Assets Ratio BioHarvest Sciences Inc.|BHST - Company Long-Term Debts|Company Short-Term Debt BioHarvest Sciences|Interim Coverage Ratio bioharvest.com
- business earnings and investment ratios data:
BHST - Company Net Income|Expected Net Profit BioHarvest Sciences|BHST - P/E Multiple|Future Price to Earnings Multiple BioHarvest Sciences, Inc.|BHST - PEG Multiple|EV/EBITDA Multiple BioHarvest Sciences Inc.|BHST - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year BioHarvest Sciences|BHST - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months bioharvest.com|BHST - Earnings growth in current year|Expected net earnings per share growth next year BioHarvest Sciences
- issuer revenue and sales details:
BHST - Company Revenue|Company Future Sales bioharvest.com
Comprehensive company analysis:bioharvest.com - BHST
Flagship merchandise of BioHarvest Sciences Inc.

BioHarvest Sciences (BHST) maintains a strong position thanks to its unique cell-free plant growth technology. A P/E valuation analysis allows for a comparison of the business's current market value against its actual net income. This ratio measures the cost of one dollar of profit, stripping the indicator of currency distortions and one-off market spikes. Investors should note that a depressed multiple may signal declining revenue, despite high loyalty to eco-products.

Key competitors

P/E Multiple haleon.com|Price to Earnings Ratio KVUE (Kenvue)|VRNA (Verona Pharma PLC) - Company Value to Net Income|Price to Earnings Ratio Jyong Biotech Corp MENS|Ligand Corp (LGND) - Market Cap to Earnings|AMRX: Price to Earnings Ratio|perrigo.com - Market Price to Net Income Ratio|ALVO: P/E Multiple|Liquidia Corp - Company Value to Net Income|GLPG (Galapagos Genomics) - P/E Multiple|Market Cap to Earnings ANI Pharmaceuticals Corp ANIP|Price to Earnings Ratio MannKind Corporation (MNKD)|AMPH (amphastar.com) - Company Value to Net Income|P/E Multiple PCRX (Pacira BioSciences, Inc.)|ARS Pharmaceuticals Inc - Price to Earnings Ratio|Theravance - P/E Multiple|Business Payback Period Aquestive Corp AQST|scpharmaceuticals.com (SCPH) - Price to Earnings Ratio|Market Cap to Earnings Tectonic Therapeutic (TECX)|TNXP (Tonix Pharmaceuticals Holding Corp.) - P/E Multiple|SXTC: Company Value to Net Income|P/E Multiple EPRX|P/E Multiple Invizyne (EXOZ)|Price to Earnings Ratio Oramed Pharmaceuticals Inc. ORMP|Company Value to Net Income ENTX|HYFT: Price to Earnings Ratio|ABVC: Price to Earnings Ratio|CPIX: P/E Multiple|Market Cap to Earnings Quantum BioPharma Corp (QNTM)|Price to Earnings Ratio FibroGen, Inc.|telomirpharma.com (TELO) - Business Payback Period|Price to Earnings Ratio RANI (Rani Therapeutics)|Market Price to Net Income Ratio SNYR|Rallybio - Price to Earnings Ratio|Company Value to Net Income LEXX|PULM - Price to Earnings Ratio|Business Payback Period Pheton Holdings Ltd PTHL|APM: P/E Multiple|Price to Earnings Ratio Lyra Therapeutics Inc.|IBO (Impact BioMedical) - P/E Multiple|TNF Pharma (TNFA) - Business Payback Period|P/E Multiple YCBD|PRFX - Market Cap to Earnings|Price to Earnings Ratio Altamira Therapeutics Ltd. CYTO|LIPO: Price to Earnings Multiple|Optinose - P/E Multiple|Pieris Pharma (PIRS) - Price to Earnings Ratio|PROC: P/E Multiple|Market Cap to Earnings petrospharma.com (PTPI)|Price to Earnings Ratio Qilian International Holding|Acelyrin Inc. (SLRN) - Business Payback Period|P/E Multiple TFFP